Julie Clark is Chief Medical Officer of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 164,723 shares of ADVM, which is worth approximately $805,495. The most recent transaction as insider was on Sep 30, 2021, when has been sold 4,766 shares (Common Stock) at a price of $2.17 per share, resulting in proceeds of $10,342. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 165K
0% 3M change
0% 12M change
Total Value Held $805,495

Julie Clark Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2021
SELL
Open market or private sale
$10,342 $2.17 p/Share
4,766 Reduced 2.81%
164,723 Common Stock
Aug 06 2021
BUY
Grant, award, or other acquisition
-
120,000 Added 41.45%
169,489 Common Stock
JC

Julie Clark

Chief Medical Officer
Redwood City, CA

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM